Cadre (NYSE:CDRE) Shares Down 4.2%

Cadre Holdings, Inc. (NYSE:CDRE - Get Free Report) was down 4.2% on Tuesday . The company traded as low as $34.38 and last traded at $34.40. Approximately 123,816 shares traded hands during mid-day trading, a decline of 51% from the average daily volume of 250,983 shares. The stock had previously closed at $35.91.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on CDRE shares. Stephens upped their target price on shares of Cadre from $36.00 to $40.00 and gave the company an "overweight" rating in a research note on Friday, February 16th. B. Riley reaffirmed a "buy" rating and set a $48.00 price objective (up from $40.00) on shares of Cadre in a research note on Wednesday, March 6th. Roth Mkm reaffirmed a "buy" rating and set a $43.00 price objective (up from $38.00) on shares of Cadre in a research note on Wednesday, March 6th. Stifel Nicolaus upped their price objective on shares of Cadre from $33.00 to $34.00 and gave the stock a "hold" rating in a research note on Wednesday, March 6th. Finally, Raymond James cut shares of Cadre from an "outperform" rating to a "market perform" rating in a research note on Monday, January 22nd. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Cadre has an average rating of "Moderate Buy" and an average target price of $41.25.

Read Our Latest Analysis on Cadre

Cadre Price Performance

The company has a debt-to-equity ratio of 0.65, a current ratio of 2.58 and a quick ratio of 1.73. The company's 50 day simple moving average is $35.78 and its two-hundred day simple moving average is $32.50. The stock has a market capitalization of $1.27 billion, a P/E ratio of 33.21, a PEG ratio of 1.93 and a beta of 1.33.


Cadre (NYSE:CDRE - Get Free Report) last released its quarterly earnings results on Tuesday, March 5th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.18 by $0.11. Cadre had a net margin of 8.01% and a return on equity of 21.85%. The business had revenue of $124.58 million for the quarter, compared to analysts' expectations of $122.30 million. As a group, equities analysts expect that Cadre Holdings, Inc. will post 1.18 EPS for the current fiscal year.

Cadre Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, February 16th. Stockholders of record on Friday, February 2nd were paid a dividend of $0.0875 per share. This is a boost from Cadre's previous quarterly dividend of $0.08. This represents a $0.35 annualized dividend and a dividend yield of 1.03%. The ex-dividend date of this dividend was Thursday, February 1st. Cadre's dividend payout ratio is 34.31%.

Insider Activity

In other news, CEO Warren B. Kanders sold 1,438,127 shares of the stock in a transaction that occurred on Tuesday, March 19th. The shares were sold at an average price of $35.00, for a total transaction of $50,334,445.00. Following the sale, the chief executive officer now directly owns 12,184,918 shares of the company's stock, valued at $426,472,130. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 49.20% of the stock is owned by insiders.

Hedge Funds Weigh In On Cadre

Several large investors have recently bought and sold shares of the business. FMR LLC lifted its holdings in Cadre by 12.4% in the third quarter. FMR LLC now owns 5,637,904 shares of the company's stock valued at $150,250,000 after buying an additional 621,116 shares during the period. Wynnefield Capital Inc. raised its holdings in Cadre by 11.1% in the second quarter. Wynnefield Capital Inc. now owns 1,444,254 shares of the company's stock worth $31,485,000 after purchasing an additional 144,056 shares during the period. BlackRock Inc. raised its holdings in Cadre by 14.8% in the second quarter. BlackRock Inc. now owns 1,250,682 shares of the company's stock worth $27,265,000 after purchasing an additional 160,955 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in Cadre by 35.5% in the second quarter. Price T Rowe Associates Inc. MD now owns 1,190,969 shares of the company's stock worth $23,426,000 after purchasing an additional 311,790 shares during the period. Finally, Vanguard Group Inc. raised its holdings in Cadre by 4.5% in the fourth quarter. Vanguard Group Inc. now owns 973,648 shares of the company's stock worth $32,023,000 after purchasing an additional 42,352 shares during the period. 43.95% of the stock is currently owned by institutional investors and hedge funds.

About Cadre

(Get Free Report)

Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.

See Also

Should you invest $1,000 in Cadre right now?

Before you consider Cadre, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cadre wasn't on the list.

While Cadre currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Featured Articles and Offers

Search Headlines: